However, much less is known about familial tumours (the remaining 5-7%), although studies [20,21,25] have noted that BRCA1 tumours are predominantly basal-like while BRCA2 tumours are more hetergeneous and may be HER2-enriched or luminal-like. The gene discussed is BRCA2; the disease is neoplasm.